Evidence map›Paper›PMID 36614275›Full record

ReviewInternational journal of molecular sciences2023

Somaclonal Variation-Advantage or Disadvantage in Micropropagation of the Medicinal Plants.

Georgiana Duta-Cornescu, Nicoleta Constantin, Daniela-Maria Pojoga, Daniela Nicuta, Alexandra Simon-Gruita

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Cytogenomic profiling ofJournal of ginseng research · 2026
    Article
  3. Article
  4. Article
  5. Plant Tissue Culture: A Short-Term Conservation Tool.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  6. A novelFrontiers in plant science · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Advancing the Potential ofMolecules (Basel, Switzerland) · 2025
    Review
  15. Optimizing Growth Regulator Concentrations forPlants (Basel, Switzerland) · 2025
    Article
  16. Molecules (Basel, Switzerland) · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Georgiana Duta-CornescuDepartment of Genetics, Faculty of Biology, University of Bucharest, 06010 Bucuresti, Romania.ORCID 0000-0002-0816-3715
Nicoleta ConstantinDepartment of Genetics, Faculty of Biology, University of Bucharest, 06010 Bucuresti, Romania.
Daniela-Maria PojogaDepartment of Genetics, Faculty of Biology, University of Bucharest, 06010 Bucuresti, Romania.ORCID 0000-0001-7281-4685
Daniela NicutaDepartment of Biology, Ecology and Environment Protection, Faculty of Science, University "Vasile Alecsandri", 600115 Bacau, Romania.
Alexandra Simon-GruitaDepartment of Genetics, Faculty of Biology, University of Bucharest, 06010 Bucuresti, Romania.ORCID 0000-0003-0856-1278

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell and tissue plant cultures are used either to save vulnerable species from extinction or to multiply valuable genotypes, or both, and are widely applied for economically important plant species. For medicinal plants, the use of in vitro technologies for the production of secondary metabolites and pathogen-free plants has been greatly developed. Two opposite aspects characterize the in vitro micropropagation of medicinal plants: maintaining genetic fidelity for the perpetuation and preservation of elites, and the identification and exploitation of somaclonal variations associated with new, useful traits. A balance between what is advantageous and what is undesirable is necessary, and this implies the identification of somaclonal variability at all levels, from the phenotypic to molecular ones. This review addresses the somaclonal variation arising from the in vitro multiplication of medicinal plants from three perspectives: cytogenetics, genetics, and epigenetics. The possible causes of the appearance of somaclones, the methods for their identification, and the extent to which they are desirable are presented comparatively for different plant species with therapeutic properties. The emphasis is on the subtle changes at the genetic and epigenetic level, as it results from the application of methods based on DNA markers.

Indexed as

Plants, MedicinalEpigenesis, GeneticGenetic MarkersGenotypePhenotypeGenetic Markersin vitro micropropagationmedicinal plantssomaclonal variation

Identifiers

PMID36614275
PMCPMC9821087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.